Trupanion’s second quarter results reflected steady revenue growth, but profitability fell short of Wall Street expectations. Management credited top-line momentum to ongoing strength in the subscription segment, increased pet acquisition spend, and improved operational discipline. CEO Margi Tooth emphasized, “We were able to deploy 16% more into pet acquisition in the quarter as we continue on the pathway to return to prior investment levels, setting up pet growth for the years to come.” Improved retention and a rebound in adjusted operating margins also contributed to the quarter’s overall performance.

Is now the time to buy TRUP? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Trupanion’s Q2 Earnings Call

• John Barnidge (Piper Sandler) asked whether the recent moderation in veterinary cost inflation could further improve loss ratios. CEO Margi Tooth and CFO Fawwad Qureshi responded that while a seasonal lift typically occurs, this quarter saw only a mild deceleration, and current guidance assumes this continues.
• Jon Block (Stifel) pressed management on the stagnant gross additions despite rising pet acquisition spend. Tooth highlighted a deliberate focus on quality over quantity, targeting higher-lifetime-value pets and turning off less profitable channels.
• Brandon Vazquez (William Blair) inquired about the mix of subscription growth between price and pet count. Qureshi clarified that about 11% of growth came from pricing and 5% from pet additions, with expectations for pet contributions to increase going forward.
• Katie Sakys (Autonomous Research) questioned the outlook for retention improvement and pricing adjustments. Tooth explained that retention is expected to improve gradually as price increases moderate, but near-term pricing changes are set for the year, with further adjustments likely in 2026 and beyond.
• Wilma Burdis (Raymond James) asked about the impact of the one-time gain from the company’s food initiative IP acquisition. Qureshi confirmed this was a non-recurring gain and explained its role in supporting future product development.

Catalysts in Upcoming Quarters

Our analyst team will be closely monitoring (1) the pace of net new pet additions as pet acquisition spending rises, (2) trends in veterinary cost inflation and their impact on pricing strategies, and (3) continued improvement in member retention as prior rate increases cycle through. Progress in launching adjacent products, especially the food initiative, may also serve as a future growth lever.

Trupanion currently trades at $50.42, up from $48.81 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.